Home > Healthcare > Biotechnology > Biotechnology R&D > Direct-to-Consumer (DTC) Genetic Testing Market
Direct-to-Consumer (DTC) Genetic Testing Market Share
- Report ID: GMI3033
- Published Date: Jan 2023
- Report Format: PDF
Direct-to-Consumer (DTC) Genetic Testing Market Share
Some of the leading companies in the global direct-to-consumer genetic testing market include
- Full Genome Corporation Inc.
- 23andMe, Inc.
- Ancestry
- Counsyl
- Gene by Gene
- Easy DNA
- Helix OpCo LLC
- Living DNA Ltd.
- Karmagenes SA
- Mapmygenome
- Pathway genomics
- Identigene
- Genesis Healthcare Co.
- The SkinDNA Company Pty Ltd
- MyHeritage
- Ambry Genetics
- DNA Genotek Inc
- Dante Lab
- Blueprint Genetics Oy
- DNA Diagnostic Center
- HomeDNA
These participants are focusing on the development of novel products to strengthen their business identity.
Frequently Asked Questions (FAQ) :
Global DTC genetic testing market was worth more than USD 3 billion in 2022 and is expected to witness over 11.5% CAGR from 2023-2032.
Single nucleotide polymorphism (SNP) chips is anticipated to exhibit over 12% CAGR over 2032 driven by their ability to improve the accuracy and efficiency of advanced DTC tests.
Europe DTC genetic testing market size is slated to reach over USD 2.7 billion by 2032 led by the presence of favorable initiatives catering to patients with rare disorders.
Ancestry, Counsyl, Easy DNA, Karmagenes SA, Mapmygenome, Identigene, MyHeritage, Dante Lab, and HomeDNA are some of the major companies in the market.
Direct-to-Consumer Genetic Testing Market Scope
×
Get a free sample of
Direct-to-Consumer Genetic Testing Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below